MedPath

The HEP-OKS Study - Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients

Phase 3
Completed
Conditions
Spatial Neglect
Cerebral Stroke
Interventions
Behavioral: hemifield eye patching (HEP) + optokinetic stimulation (OKS)
Registration Number
NCT01617343
Lead Sponsor
University of Luebeck
Brief Summary

Spatial neglect represents one of the major cognitive disorders following stroke. Patients patients fail to be aware of objects or people to their left and orientate instead to their right side. Enduring neglect has been found to be a poor prognostic indicator for functional independence following stroke. Despite some promising experimental accounts there are no established treatments for this condition.

The aim of this study is to test whether a combined treatment with hemifield eye patching (HEP) and optokinetic stimulation (OKS) can permanently reduce neglect behaviour and improve functional outcome in patients with hemispatial neglect following stroke.

The investigators hypothesise that the treatment with HEP and OKS will lead to a greater reduction of neglect scoring in the neglect test battery as well as a greater improvement in functional independence scores as compared to the spontaneous clinical course of the usual-care control group.

Detailed Description

To specify, this study should answer the following main question: Does the daily wearing of hemifield eye patches over a period of 1 week in combination with daily sessions of optokinetic stimulation lead to a significant reduction of neglect behaviour as measured by total scores in a paper-and-pencil neglect test battery and/or an improvement in functional independence scores (Catherine-Bergego-Scale, Barthel Index) in a cohort of stroke patients with acute hemispatial neglect as compared to the spontaneous course of the disease in a control patient group without a neglect-specific treatment?

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Right hemisphere stroke
  • Spatial neglect as determined by pathological scores in at least two tests of a neglect test battery (Azouvi et al., JNNP, 2004)
  • Age > 18 years old
  • Informed consent signature
Exclusion Criteria
  • Bilateral or previous unilateral stroke lesions
  • Pre-existing neurodegenerative disease
  • Inability to give informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HEP-OKShemifield eye patching (HEP) + optokinetic stimulation (OKS)-
Primary Outcome Measures
NameTimeMethod
Total score in a neglect test batteryChange from baseline at Day 8 (post-treatment)

Performance in a neglect test battery (score between 0 and 100%) consisting of standard neglect tests including two cancellation tasks, line bisection, figure copying and text reading

Functional independence scoreChange from baseline at Day 8 (post-treatment)

Level of functional independence (score between 0 and 100%) as measured by the Barthel-Index and the Catherine-Bergego-Scale

Secondary Outcome Measures
NameTimeMethod
Total score in the neglect test battery at follow-upChange from baseline at Day 30

For details please see primary outcome measure

Functional independence score at follow-upChange from baseline at Day 30

For details please see primary outcome measure

Performance in paper-and-pencil subtestsChange from baseline at Day 8 and at Day 30

The secondary outcome measures include scores of the individual subtests of the neglect test battery, i.e. bells and star cancellation tasks, line bisection, figure copying and text reading.

Performance in computerized attention testsChange from baseline at Day 8 and at Day 30

Performance in two computerized attention tests. These comprise a Posner Attention Task and a visual search task including eye movement analyses.

MRIDay 1

All patients (without contraindications) undergo cranial Magnetic Resonance Imaging (MRI) including 3D lesion analysis, resting state fMRI and a task-related fMRI with optokinetic stimuli. Patients' MRI data will be correlated to behavioural performance (see primary and other secondary outcome measures) and will also be compared to controls without spatial neglect.

Trial Locations

Locations (1)

University of Luebeck, Dept. of Neurology

🇩🇪

Luebeck, Schleswig-Holstein, Germany

© Copyright 2025. All Rights Reserved by MedPath